The IL-23/IL-17 pathway in human chronic inflammatory diseases – new insight from genetics and targeted therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The IL-23/IL-17 pathway in human chronic inflammatory diseases – new insight from genetics and targeted therapies

Published:2019-06 Issue:5-6 Volume:21 Page:246-253
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Bianchi Elisabetta,Rogge Lars

Funder

Institut Pasteur, FOREUM Foundation for Research in Rheumatology

Fondation Arthritis and MSD Avenir

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference97 articles.

1. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities;El-Gabalawy;J Rheumatol Suppl,2010

2. Genetic insights into common pathways and complex relationships among immune-mediated diseases;Parkes;Nat Rev Genet,2013

3. Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes;Westra;Nat Genet,2018

4. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits;Diogo;PLoS One,2015

5. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers;Onengut-Gumuscu;Nat Genet,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immobilized recombinant laccase over PEGylated silica-coated magnetic nanoparticles for anti-inflammatory modulation in pro-monocytic model cell line;Process Biochemistry;2024-11

2. Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background;The American Journal of Human Genetics;2023-10

3. Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study;Expert Opinion on Investigational Drugs;2023-06-29

4. Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?;Current Issues in Molecular Biology;2023-05-15

5. Is chronic pain as an autoimmune disease?;Canadian Journal of Pain;2022-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3